Clinical Trial Update: SERETIDE 100/50 bd (Twice Daily) Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In Adults [Phase 4]

View source ↗

Summary

A Phase 4 trial compared Seretide 100/50 twice daily to Flixotide 100 twice daily as initial maintenance therapy in adults with moderate asthma; results were co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Flixotide 100 (fluticasone propionate)
• Seretide 100/50 (fluticasone propionate/salmeterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2012-03-23